| published | held | entry | result |
|---|---|---|---|
| 2026-10-09 | 63d | $261.44 | open |
| 2026-10-08 | 63d | $256.48 | open |
| 2026-10-07 | 63d | $258.45 | open |
| 2026-10-06 | 63d | $254.78 | open |
| 2026-10-06 | 21d | $254.78 | open |
| 2026-10-05 | 63d | $252.93 | open |
| 2026-10-05 | 21d | $252.93 | open |
| 2026-10-05 | 10d | $254.15 | +1.3% (time) |
| 2026-10-02 | 63d | $256.03 | open |
| 2026-10-02 | 21d | $256.03 | open |
| 2026-08-14 | 63d | $260.35 | open |
| 2026-08-04 | 63d | $254.93 | open |
| 2026-08-03 | 63d | $254.41 | open |
| 2026-07-31 | 63d | $256.35 | open |
| 2026-07-17 | 63d | $250.77 | +1.9% (time) |
| 2026-07-16 | 63d | $251.35 | +2.3% (time) |
| 2026-07-16 | 21d | $252.59 | +2.5% (time) |
| 2026-07-15 | 63d | $247.68 | +0.6% (time) |
| 2026-07-13 | 21d | $255.53 | +0.2% (time) |
| 2026-07-10 | 21d | $257.95 | +1.3% (time) |
| 2026-07-09 | 21d | $260.19 | -0.4% (time) |
| 2026-07-09 | 10d | $260.19 | -4.3% (stop) |
| 2026-07-08 | 10d | $260.63 | -2.8% (stop) |
| 2026-07-06 | 21d | $264.89 | -3.6% (time) |
| 2026-07-06 | 10d | $264.89 | -5.8% (stop) |
| 2026-07-02 | 10d | $260.23 | -2.5% (stop) |
| 2026-07-01 | 10d | $255.78 | -1.2% (time) |
| 2026-06-30 | 10d | $253.25 | -1.7% (time) |
| 2026-06-29 | 10d | $259.00 | -3.6% (stop) |
| 2026-06-22 | 21d | $235.64 | +8.3% (time) |
| 2026-06-18 | 21d | $228.95 | +10.4% (time) |
| 2026-06-18 | 10d | $228.95 | +15.7% (time) |
| 2026-06-17 | 21d | $231.78 | +6.8% (time) |
| 2026-06-16 | 21d | $234.03 | +7.7% (time) |
| 2026-06-08 | 21d | $232.38 | +12.0% (time) |
| 2026-06-08 | 10d | $232.38 | +3.2% (time) |
| 2026-06-05 | 21d | $232.77 | +12.0% (time) |
| 2026-06-04 | 10d | $230.00 | -0.5% (time) |
| 2026-06-04 | 21d | $230.00 | +16.8% (time) |
Every idea was timestamped before its outcome was known. We publish the losers alongside the winners.
| 2026-10-22 | Alzheimer's Disease Clinical Trial and Competitive Landscape Enters a New Phase as 200+ Companies Advance Clinical Programs | DelveInsight | GlobeNewswire Inc. |
| 2026-10-21 | Vanguard Health Care ETF vs iShares U.S. Healthcare ETF | The Motley Fool |
| 2026-10-21 | Abbott: 3 Key Takeaways for Long-Term Investors | The Motley Fool |
| 2026-10-21 | Global Oral Drugs Market is Predicted to Surpass USD 1 Trillion Mark by 2034 | DelveInsight | GlobeNewswire Inc. |
| 2026-10-21 | Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 | The Motley Fool |
| 2026-10-21 | Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now? | Zacks Investment Research |
| 2026-10-20 | 2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) | The Motley Fool |
| 2026-10-20 | GSK's New Drugs and Pipeline Hold the Key to Long-Term Growth | Zacks Investment Research |
Educational information, not financial advice.